|
US2020003762A1
|
|
Diagnostics Platform for Mitochondrial Dysfunctions/Diseases
|
|
US2020121618A1
|
|
Methods and compositions for treatment of inflammation and oxidative stress
|
|
US2018333389A1
|
|
Vitamin e compositions and methods of use therefor
|
|
WO2018129411A1
|
|
Aryl- and heteroaryl-resorufin derivatives for treatment of oxidative stress disorders and liver and kidney disorders
|
|
WO2018093957A1
|
|
2-substituted amino-naphth[1,2-d]imidazol-5-one compounds or pharmaceutically acceptable salts thereof cross reference to related applications
|
|
WO2018081644A1
|
|
Methods of analyzing p-hydroquinone levels and ratios
|
|
US2019048306A1
|
|
Redox-related context adjustments to a bioprocess monitored by learning systems and methods based on redox indicators
|
|
US2019050533A1
|
|
Redox-related context adjustments to a reference bioprocess model used in learning systems and methods based on redox indicators
|
|
US2019050532A1
|
|
Distributed systems and methods for learning about a bioprocess from redox indicators and local conditions
|
|
WO2017123823A1
|
|
Alkyl-, acyl-, urea-, and aza-uracil sulfide:quinone oxidoreductase inhibitors
|
|
WO2017123822A1
|
|
Tocopherol and tocotrienol quinone derivatives for increasing thiosulfate levels or decreasing hydrogen sulfide levels
|
|
JP2018083799A
|
|
2-SUBSTITUTED AMINO-NAPHTHO[1,2-d]IMIDAZOLE-5-ONE COMPOUND OR PHARMACEUTICALLY ALLOWABLE SALTS THEREOF
|
|
WO2017106786A1
|
|
Improved methods for enriching alpha-tocotrienol from mixed tocol compositions
|
|
EP3233819A1
|
|
Methods for chiral resolution of trolox
|
|
SG11201704968XA
|
|
Polymorphic and amorphous forms of (r)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
|
|
US2016039776A1
|
|
Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
|
|
US2016039775A1
|
|
Resorufin derivatives for treatment of oxidative stress disorders
|
|
BRPI1013376A2
|
|
treatment of hereditary leber optic neuropath and dominant optic atrophy with tocotrienol quinones.
|
|
CA2974482A1
|
|
High purity alpha tocotrienol quinone and processes for preparing same
|
|
EP2362726A1
|
|
Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells
|
